nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCG2—Cladribine—multiple sclerosis	0.113	0.141	CbGbCtD
Rilpivirine—ABCG2—Mitoxantrone—multiple sclerosis	0.0821	0.103	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—multiple sclerosis	0.0739	0.0929	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—multiple sclerosis	0.0431	0.0541	CbGbCtD
Rilpivirine—ABCG2—Dexamethasone—multiple sclerosis	0.0426	0.0535	CbGbCtD
Rilpivirine—ABCB1—Methylprednisolone—multiple sclerosis	0.0406	0.051	CbGbCtD
Rilpivirine—CYP3A4—Fingolimod—multiple sclerosis	0.0377	0.0474	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—multiple sclerosis	0.0342	0.043	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—multiple sclerosis	0.0305	0.0383	CbGbCtD
Rilpivirine—CYP2B6—Dexamethasone—multiple sclerosis	0.0299	0.0376	CbGbCtD
Rilpivirine—ABCB1—Mitoxantrone—multiple sclerosis	0.0296	0.0372	CbGbCtD
Rilpivirine—ABCB1—Betamethasone—multiple sclerosis	0.0264	0.0331	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—multiple sclerosis	0.026	0.0327	CbGbCtD
Rilpivirine—ABCB1—Prednisone—multiple sclerosis	0.0246	0.0309	CbGbCtD
Rilpivirine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0243	0.0305	CbGbCtD
Rilpivirine—CYP2C19—Dexamethasone—multiple sclerosis	0.019	0.0239	CbGbCtD
Rilpivirine—CYP3A4—Triamcinolone—multiple sclerosis	0.0184	0.0231	CbGbCtD
Rilpivirine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0177	0.0223	CbGbCtD
Rilpivirine—CYP3A4—Betamethasone—multiple sclerosis	0.0158	0.0199	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—multiple sclerosis	0.0156	0.0196	CbGbCtD
Rilpivirine—ABCB1—Dexamethasone—multiple sclerosis	0.0153	0.0193	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—multiple sclerosis	0.0147	0.0185	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—multiple sclerosis	0.0123	0.0155	CbGbCtD
Rilpivirine—Autoimmune disorder—Fingolimod—multiple sclerosis	0.00931	0.0629	CcSEcCtD
Rilpivirine—CYP3A4—Dexamethasone—multiple sclerosis	0.00919	0.0115	CbGbCtD
Rilpivirine—Hepatitis B—Azathioprine—multiple sclerosis	0.00784	0.053	CcSEcCtD
Rilpivirine—Depressed mood—Fingolimod—multiple sclerosis	0.00695	0.047	CcSEcCtD
Rilpivirine—Opportunistic infection—Cladribine—multiple sclerosis	0.00437	0.0296	CcSEcCtD
Rilpivirine—Buffalo hump—Prednisone—multiple sclerosis	0.00344	0.0232	CcSEcCtD
Rilpivirine—Adrenal insufficiency—Prednisone—multiple sclerosis	0.00329	0.0223	CcSEcCtD
Rilpivirine—Lipohypertrophy—Prednisone—multiple sclerosis	0.00316	0.0214	CcSEcCtD
Rilpivirine—Cholecystitis—Cladribine—multiple sclerosis	0.00307	0.0207	CcSEcCtD
Rilpivirine—White blood cell count decreased—Mitoxantrone—multiple sclerosis	0.00233	0.0157	CcSEcCtD
Rilpivirine—Opportunistic infection—Methylprednisolone—multiple sclerosis	0.00216	0.0146	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Fingolimod—multiple sclerosis	0.00203	0.0137	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Fingolimod—multiple sclerosis	0.00199	0.0134	CcSEcCtD
Rilpivirine—Opportunistic infection—Betamethasone—multiple sclerosis	0.00197	0.0133	CcSEcCtD
Rilpivirine—Opportunistic infection—Dexamethasone—multiple sclerosis	0.00197	0.0133	CcSEcCtD
Rilpivirine—Depressed mood—Methylprednisolone—multiple sclerosis	0.00195	0.0132	CcSEcCtD
Rilpivirine—Platelet count decreased—Mitoxantrone—multiple sclerosis	0.00195	0.0132	CcSEcCtD
Rilpivirine—Serum creatinine increased—Mitoxantrone—multiple sclerosis	0.00188	0.0127	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Cladribine—multiple sclerosis	0.00186	0.0126	CcSEcCtD
Rilpivirine—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00185	0.0125	CcSEcCtD
Rilpivirine—Inflammation—Cladribine—multiple sclerosis	0.00182	0.0123	CcSEcCtD
Rilpivirine—Depression—Fingolimod—multiple sclerosis	0.00173	0.0117	CcSEcCtD
Rilpivirine—Opportunistic infection—Prednisone—multiple sclerosis	0.00171	0.0116	CcSEcCtD
Rilpivirine—Haemoglobin decreased—Mitoxantrone—multiple sclerosis	0.00168	0.0114	CcSEcCtD
Rilpivirine—Opportunistic infection—Methotrexate—multiple sclerosis	0.00143	0.00968	CcSEcCtD
Rilpivirine—Mental disorder—Fingolimod—multiple sclerosis	0.00137	0.00924	CcSEcCtD
Rilpivirine—Renal impairment—Cladribine—multiple sclerosis	0.00134	0.00908	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Mitoxantrone—multiple sclerosis	0.00122	0.00827	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00115	0.00776	CcSEcCtD
Rilpivirine—Infection—Fingolimod—multiple sclerosis	0.0011	0.00744	CcSEcCtD
Rilpivirine—Nervous system disorder—Fingolimod—multiple sclerosis	0.00109	0.00735	CcSEcCtD
Rilpivirine—Skin disorder—Fingolimod—multiple sclerosis	0.00108	0.00728	CcSEcCtD
Rilpivirine—Abdominal discomfort—Cladribine—multiple sclerosis	0.00106	0.00716	CcSEcCtD
Rilpivirine—Renal failure—Cladribine—multiple sclerosis	0.000968	0.00654	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000957	0.00647	CcSEcCtD
Rilpivirine—Fatigue—Fingolimod—multiple sclerosis	0.000956	0.00646	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Cladribine—multiple sclerosis	0.000932	0.0063	CcSEcCtD
Rilpivirine—Inflammation—Methylprednisolone—multiple sclerosis	0.000898	0.00607	CcSEcCtD
Rilpivirine—Urinary tract disorder—Cladribine—multiple sclerosis	0.000873	0.0059	CcSEcCtD
Rilpivirine—Urethral disorder—Cladribine—multiple sclerosis	0.000867	0.00586	CcSEcCtD
Rilpivirine—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000861	0.00582	CcSEcCtD
Rilpivirine—Immune system disorder—Cladribine—multiple sclerosis	0.000799	0.0054	CcSEcCtD
Rilpivirine—Asthenia—Fingolimod—multiple sclerosis	0.000795	0.00537	CcSEcCtD
Rilpivirine—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.000787	0.00532	CcSEcCtD
Rilpivirine—Mental disorder—Cladribine—multiple sclerosis	0.000775	0.00524	CcSEcCtD
Rilpivirine—Malnutrition—Cladribine—multiple sclerosis	0.00077	0.0052	CcSEcCtD
Rilpivirine—Diarrhoea—Fingolimod—multiple sclerosis	0.000758	0.00513	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.000758	0.00512	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000757	0.00511	CcSEcCtD
Rilpivirine—Hepatotoxicity—Methotrexate—multiple sclerosis	0.000747	0.00505	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000741	0.00501	CcSEcCtD
Rilpivirine—Dizziness—Fingolimod—multiple sclerosis	0.000733	0.00495	CcSEcCtD
Rilpivirine—Headache—Fingolimod—multiple sclerosis	0.000694	0.00469	CcSEcCtD
Rilpivirine—Anxiety—Cladribine—multiple sclerosis	0.000653	0.00441	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000651	0.0044	CcSEcCtD
Rilpivirine—Immune system disorder—Azathioprine—multiple sclerosis	0.00065	0.00439	CcSEcCtD
Rilpivirine—Renal failure—Mitoxantrone—multiple sclerosis	0.000637	0.0043	CcSEcCtD
Rilpivirine—Infection—Cladribine—multiple sclerosis	0.000624	0.00422	CcSEcCtD
Rilpivirine—Nervous system disorder—Cladribine—multiple sclerosis	0.000616	0.00416	CcSEcCtD
Rilpivirine—Skin disorder—Cladribine—multiple sclerosis	0.00061	0.00412	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—multiple sclerosis	0.000595	0.00402	CcSEcCtD
Rilpivirine—Insomnia—Cladribine—multiple sclerosis	0.000568	0.00384	CcSEcCtD
Rilpivirine—Somnolence—Cladribine—multiple sclerosis	0.000559	0.00378	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000558	0.00377	CcSEcCtD
Rilpivirine—Decreased appetite—Cladribine—multiple sclerosis	0.000546	0.00369	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000542	0.00367	CcSEcCtD
Rilpivirine—Fatigue—Cladribine—multiple sclerosis	0.000542	0.00366	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000529	0.00358	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000514	0.00347	CcSEcCtD
Rilpivirine—Infection—Azathioprine—multiple sclerosis	0.000508	0.00343	CcSEcCtD
Rilpivirine—Abdominal pain—Cladribine—multiple sclerosis	0.000497	0.00336	CcSEcCtD
Rilpivirine—Skin disorder—Azathioprine—multiple sclerosis	0.000496	0.00335	CcSEcCtD
Rilpivirine—Asthenia—Cladribine—multiple sclerosis	0.000451	0.00305	CcSEcCtD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000447	0.00798	CbGpPWpGaD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000447	0.00798	CbGpPWpGaD
Rilpivirine—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000442	0.00299	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000441	0.00298	CcSEcCtD
Rilpivirine—Diarrhoea—Cladribine—multiple sclerosis	0.00043	0.00291	CcSEcCtD
Rilpivirine—Anxiety—Mitoxantrone—multiple sclerosis	0.000429	0.0029	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000418	0.00282	CcSEcCtD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000416	0.00744	CbGpPWpGaD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000416	0.00744	CbGpPWpGaD
Rilpivirine—Dizziness—Cladribine—multiple sclerosis	0.000416	0.00281	CcSEcCtD
Rilpivirine—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000411	0.00734	CbGpPWpGaD
Rilpivirine—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000411	0.00734	CbGpPWpGaD
Rilpivirine—Infection—Mitoxantrone—multiple sclerosis	0.00041	0.00277	CcSEcCtD
Rilpivirine—Abdominal pain—Azathioprine—multiple sclerosis	0.000404	0.00273	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000402	0.00719	CbGpPWpGaD
Rilpivirine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000401	0.00271	CcSEcCtD
Rilpivirine—Vomiting—Cladribine—multiple sclerosis	0.0004	0.0027	CcSEcCtD
Rilpivirine—Rash—Cladribine—multiple sclerosis	0.000396	0.00268	CcSEcCtD
Rilpivirine—Dermatitis—Cladribine—multiple sclerosis	0.000396	0.00268	CcSEcCtD
Rilpivirine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000395	0.00267	CcSEcCtD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000394	0.00705	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000394	0.00705	CbGpPWpGaD
Rilpivirine—Headache—Cladribine—multiple sclerosis	0.000394	0.00266	CcSEcCtD
Rilpivirine—Depression—Prednisone—multiple sclerosis	0.000385	0.0026	CcSEcCtD
Rilpivirine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000383	0.00259	CcSEcCtD
Rilpivirine—Malnutrition—Methylprednisolone—multiple sclerosis	0.000381	0.00257	CcSEcCtD
Rilpivirine—Nausea—Cladribine—multiple sclerosis	0.000373	0.00252	CcSEcCtD
Rilpivirine—SLCO1B3—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000373	0.00666	CbGpPWpGaD
Rilpivirine—Somnolence—Mitoxantrone—multiple sclerosis	0.000367	0.00248	CcSEcCtD
Rilpivirine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000365	0.00652	CbGpPWpGaD
Rilpivirine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000359	0.00243	CcSEcCtD
Rilpivirine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000357	0.00638	CbGpPWpGaD
Rilpivirine—Fatigue—Mitoxantrone—multiple sclerosis	0.000356	0.00241	CcSEcCtD
Rilpivirine—Diarrhoea—Azathioprine—multiple sclerosis	0.00035	0.00236	CcSEcCtD
Rilpivirine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000349	0.00624	CbGpPWpGaD
Rilpivirine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000347	0.00234	CcSEcCtD
Rilpivirine—Dizziness—Azathioprine—multiple sclerosis	0.000338	0.00228	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000338	0.00228	CcSEcCtD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000337	0.00603	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000337	0.00603	CbGpPWpGaD
Rilpivirine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000327	0.00221	CcSEcCtD
Rilpivirine—Vomiting—Azathioprine—multiple sclerosis	0.000325	0.0022	CcSEcCtD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000324	0.0058	CbGpPWpGaD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000324	0.0058	CbGpPWpGaD
Rilpivirine—Anxiety—Methylprednisolone—multiple sclerosis	0.000323	0.00218	CcSEcCtD
Rilpivirine—Rash—Azathioprine—multiple sclerosis	0.000322	0.00218	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000322	0.00218	CcSEcCtD
Rilpivirine—Dermatitis—Azathioprine—multiple sclerosis	0.000322	0.00218	CcSEcCtD
Rilpivirine—Depression—Methotrexate—multiple sclerosis	0.000322	0.00217	CcSEcCtD
Rilpivirine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00032	0.00572	CbGpPWpGaD
Rilpivirine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00032	0.00572	CbGpPWpGaD
Rilpivirine—Headache—Azathioprine—multiple sclerosis	0.00032	0.00216	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—ZNF746—multiple sclerosis	0.000318	0.00569	CbGpPWpGaD
Rilpivirine—Dry mouth—Triamcinolone—multiple sclerosis	0.000318	0.00215	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—multiple sclerosis	0.000317	0.00214	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—multiple sclerosis	0.000313	0.00212	CcSEcCtD
Rilpivirine—Infection—Triamcinolone—multiple sclerosis	0.00031	0.00209	CcSEcCtD
Rilpivirine—Infection—Methylprednisolone—multiple sclerosis	0.000309	0.00209	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—multiple sclerosis	0.000306	0.00207	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000305	0.00206	CcSEcCtD
Rilpivirine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000305	0.00206	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000305	0.00545	CbGpPWpGaD
Rilpivirine—Mental disorder—Prednisone—multiple sclerosis	0.000304	0.00205	CcSEcCtD
Rilpivirine—Nausea—Azathioprine—multiple sclerosis	0.000303	0.00205	CcSEcCtD
Rilpivirine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000302	0.00204	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—multiple sclerosis	0.000302	0.00204	CcSEcCtD
Rilpivirine—Asthenia—Mitoxantrone—multiple sclerosis	0.000296	0.002	CcSEcCtD
Rilpivirine—Anxiety—Dexamethasone—multiple sclerosis	0.000294	0.00199	CcSEcCtD
Rilpivirine—Anxiety—Betamethasone—multiple sclerosis	0.000294	0.00199	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—PTBP1—multiple sclerosis	0.000291	0.0052	CbGpPWpGaD
Rilpivirine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000286	0.00193	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—multiple sclerosis	0.000284	0.00192	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000284	0.00507	CbGpPWpGaD
Rilpivirine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000283	0.00191	CcSEcCtD
Rilpivirine—Insomnia—Triamcinolone—multiple sclerosis	0.000282	0.0019	CcSEcCtD
Rilpivirine—Insomnia—Methylprednisolone—multiple sclerosis	0.000281	0.0019	CcSEcCtD
Rilpivirine—Infection—Dexamethasone—multiple sclerosis	0.000281	0.0019	CcSEcCtD
Rilpivirine—Infection—Betamethasone—multiple sclerosis	0.000281	0.0019	CcSEcCtD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000278	0.00497	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000277	0.00187	CcSEcCtD
Rilpivirine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000277	0.00187	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000277	0.00495	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00027	0.00483	CbGpPWpGaD
Rilpivirine—Fatigue—Triamcinolone—multiple sclerosis	0.000269	0.00182	CcSEcCtD
Rilpivirine—Fatigue—Methylprednisolone—multiple sclerosis	0.000268	0.00181	CcSEcCtD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000263	0.0047	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000263	0.0047	CbGpPWpGaD
Rilpivirine—Vomiting—Mitoxantrone—multiple sclerosis	0.000263	0.00177	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—multiple sclerosis	0.000262	0.00177	CcSEcCtD
Rilpivirine—Rash—Mitoxantrone—multiple sclerosis	0.00026	0.00176	CcSEcCtD
Rilpivirine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00026	0.00176	CcSEcCtD
Rilpivirine—Headache—Mitoxantrone—multiple sclerosis	0.000259	0.00175	CcSEcCtD
Rilpivirine—Anxiety—Prednisone—multiple sclerosis	0.000256	0.00173	CcSEcCtD
Rilpivirine—Insomnia—Dexamethasone—multiple sclerosis	0.000256	0.00173	CcSEcCtD
Rilpivirine—Insomnia—Betamethasone—multiple sclerosis	0.000256	0.00173	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000255	0.00172	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000254	0.00172	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—multiple sclerosis	0.000254	0.00171	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—multiple sclerosis	0.000252	0.0017	CcSEcCtD
Rilpivirine—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.00025	0.00448	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00025	0.00447	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00025	0.00447	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000247	0.00442	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000247	0.00442	CbGpPWpGaD
Rilpivirine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000246	0.00166	CcSEcCtD
Rilpivirine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000246	0.00166	CcSEcCtD
Rilpivirine—Decreased appetite—Betamethasone—multiple sclerosis	0.000246	0.00166	CcSEcCtD
Rilpivirine—Nausea—Mitoxantrone—multiple sclerosis	0.000245	0.00166	CcSEcCtD
Rilpivirine—Infection—Prednisone—multiple sclerosis	0.000245	0.00165	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000244	0.00165	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000244	0.00165	CcSEcCtD
Rilpivirine—Fatigue—Dexamethasone—multiple sclerosis	0.000244	0.00165	CcSEcCtD
Rilpivirine—Fatigue—Betamethasone—multiple sclerosis	0.000244	0.00165	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—multiple sclerosis	0.000241	0.00163	CcSEcCtD
Rilpivirine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.00024	0.00429	CbGpPWpGaD
Rilpivirine—Skin disorder—Prednisone—multiple sclerosis	0.000239	0.00162	CcSEcCtD
Rilpivirine—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000237	0.00424	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000237	0.00424	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000234	0.00418	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000234	0.00418	CbGpPWpGaD
Rilpivirine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000231	0.00156	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000231	0.00156	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000226	0.00404	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000226	0.00404	CbGpPWpGaD
Rilpivirine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000225	0.00401	CbGpPWpGaD
Rilpivirine—Dizziness—Prednisolone—multiple sclerosis	0.000224	0.00151	CcSEcCtD
Rilpivirine—Asthenia—Triamcinolone—multiple sclerosis	0.000224	0.00151	CcSEcCtD
Rilpivirine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000224	0.00151	CcSEcCtD
Rilpivirine—Abdominal pain—Betamethasone—multiple sclerosis	0.000224	0.00151	CcSEcCtD
Rilpivirine—Asthenia—Methylprednisolone—multiple sclerosis	0.000223	0.00151	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—multiple sclerosis	0.000223	0.00151	CcSEcCtD
Rilpivirine—NR1I2—Gene Expression—U2AF2—multiple sclerosis	0.00022	0.00394	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HNRNPA1—multiple sclerosis	0.00022	0.00394	CbGpPWpGaD
Rilpivirine—Decreased appetite—Prednisone—multiple sclerosis	0.000214	0.00145	CcSEcCtD
Rilpivirine—Rash—Prednisolone—multiple sclerosis	0.000214	0.00144	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—multiple sclerosis	0.000213	0.00144	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000213	0.00144	CcSEcCtD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000213	0.00381	CbGpPWpGaD
Rilpivirine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000213	0.00144	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—multiple sclerosis	0.000212	0.00143	CcSEcCtD
Rilpivirine—Headache—Prednisolone—multiple sclerosis	0.000212	0.00143	CcSEcCtD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000209	0.00374	CbGpPWpGaD
Rilpivirine—Dizziness—Triamcinolone—multiple sclerosis	0.000206	0.00139	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000206	0.00367	CbGpPWpGaD
Rilpivirine—Dizziness—Methylprednisolone—multiple sclerosis	0.000206	0.00139	CcSEcCtD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000205	0.00366	CbGpPWpGaD
Rilpivirine—Infection—Methotrexate—multiple sclerosis	0.000204	0.00138	CcSEcCtD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000204	0.00365	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000203	0.00363	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000203	0.00363	CbGpPWpGaD
Rilpivirine—Asthenia—Dexamethasone—multiple sclerosis	0.000203	0.00137	CcSEcCtD
Rilpivirine—Asthenia—Betamethasone—multiple sclerosis	0.000203	0.00137	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000202	0.00136	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000201	0.00136	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—multiple sclerosis	0.000201	0.00136	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—multiple sclerosis	0.0002	0.00135	CcSEcCtD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.0002	0.00357	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.0002	0.00357	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—PGR—multiple sclerosis	0.000199	0.00356	CbGpPWpGaD
Rilpivirine—Vomiting—Triamcinolone—multiple sclerosis	0.000198	0.00134	CcSEcCtD
Rilpivirine—Vomiting—Methylprednisolone—multiple sclerosis	0.000198	0.00134	CcSEcCtD
Rilpivirine—Rash—Triamcinolone—multiple sclerosis	0.000196	0.00133	CcSEcCtD
Rilpivirine—Dermatitis—Triamcinolone—multiple sclerosis	0.000196	0.00133	CcSEcCtD
Rilpivirine—Rash—Methylprednisolone—multiple sclerosis	0.000196	0.00132	CcSEcCtD
Rilpivirine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000196	0.00132	CcSEcCtD
Rilpivirine—Headache—Triamcinolone—multiple sclerosis	0.000195	0.00132	CcSEcCtD
Rilpivirine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000195	0.00349	CbGpPWpGaD
Rilpivirine—Headache—Methylprednisolone—multiple sclerosis	0.000195	0.00132	CcSEcCtD
Rilpivirine—Abdominal pain—Prednisone—multiple sclerosis	0.000195	0.00132	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000194	0.00347	CbGpPWpGaD
Rilpivirine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000193	0.00131	CcSEcCtD
Rilpivirine—Diarrhoea—Betamethasone—multiple sclerosis	0.000193	0.00131	CcSEcCtD
Rilpivirine—Dizziness—Betamethasone—multiple sclerosis	0.000187	0.00126	CcSEcCtD
Rilpivirine—Dizziness—Dexamethasone—multiple sclerosis	0.000187	0.00126	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—multiple sclerosis	0.000186	0.00126	CcSEcCtD
Rilpivirine—Nausea—Triamcinolone—multiple sclerosis	0.000185	0.00125	CcSEcCtD
Rilpivirine—Nausea—Methylprednisolone—multiple sclerosis	0.000185	0.00125	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—multiple sclerosis	0.000183	0.00124	CcSEcCtD
Rilpivirine—Vomiting—Dexamethasone—multiple sclerosis	0.00018	0.00121	CcSEcCtD
Rilpivirine—Vomiting—Betamethasone—multiple sclerosis	0.00018	0.00121	CcSEcCtD
Rilpivirine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000179	0.0032	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000179	0.0032	CbGpPWpGaD
Rilpivirine—Decreased appetite—Methotrexate—multiple sclerosis	0.000179	0.00121	CcSEcCtD
Rilpivirine—Rash—Dexamethasone—multiple sclerosis	0.000178	0.0012	CcSEcCtD
Rilpivirine—Rash—Betamethasone—multiple sclerosis	0.000178	0.0012	CcSEcCtD
Rilpivirine—Dermatitis—Dexamethasone—multiple sclerosis	0.000178	0.0012	CcSEcCtD
Rilpivirine—Dermatitis—Betamethasone—multiple sclerosis	0.000178	0.0012	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000178	0.0012	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—multiple sclerosis	0.000177	0.0012	CcSEcCtD
Rilpivirine—Headache—Dexamethasone—multiple sclerosis	0.000177	0.0012	CcSEcCtD
Rilpivirine—Headache—Betamethasone—multiple sclerosis	0.000177	0.0012	CcSEcCtD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000177	0.00316	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000177	0.00316	CbGpPWpGaD
Rilpivirine—Asthenia—Prednisone—multiple sclerosis	0.000177	0.00119	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000176	0.00315	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000175	0.00312	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ZFP36L1—multiple sclerosis	0.000174	0.00312	CbGpPWpGaD
Rilpivirine—Diarrhoea—Prednisone—multiple sclerosis	0.000168	0.00114	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000168	0.00114	CcSEcCtD
Rilpivirine—Nausea—Betamethasone—multiple sclerosis	0.000168	0.00113	CcSEcCtD
Rilpivirine—Nausea—Dexamethasone—multiple sclerosis	0.000168	0.00113	CcSEcCtD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000167	0.00299	CbGpPWpGaD
Rilpivirine—Dizziness—Prednisone—multiple sclerosis	0.000163	0.0011	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—multiple sclerosis	0.000163	0.0011	CcSEcCtD
Rilpivirine—Vomiting—Prednisone—multiple sclerosis	0.000157	0.00106	CcSEcCtD
Rilpivirine—Rash—Prednisone—multiple sclerosis	0.000155	0.00105	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—multiple sclerosis	0.000155	0.00105	CcSEcCtD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000155	0.00277	CbGpPWpGaD
Rilpivirine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000154	0.00276	CbGpPWpGaD
Rilpivirine—Headache—Prednisone—multiple sclerosis	0.000154	0.00104	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000153	0.00273	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000152	0.00272	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000148	0.00265	CbGpPWpGaD
Rilpivirine—Asthenia—Methotrexate—multiple sclerosis	0.000148	0.000998	CcSEcCtD
Rilpivirine—Nausea—Prednisone—multiple sclerosis	0.000146	0.000988	CcSEcCtD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000143	0.00256	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000142	0.00254	CbGpPWpGaD
Rilpivirine—Diarrhoea—Methotrexate—multiple sclerosis	0.000141	0.000952	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000141	0.00252	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00014	0.0025	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00014	0.0025	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—VDR—multiple sclerosis	0.000139	0.00249	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000138	0.00246	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000138	0.00246	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000137	0.00245	CbGpPWpGaD
Rilpivirine—Dizziness—Methotrexate—multiple sclerosis	0.000136	0.00092	CcSEcCtD
Rilpivirine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000135	0.00242	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PABPC1—multiple sclerosis	0.000135	0.00242	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000134	0.0024	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000134	0.0024	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000133	0.00238	CbGpPWpGaD
Rilpivirine—Vomiting—Methotrexate—multiple sclerosis	0.000131	0.000884	CcSEcCtD
Rilpivirine—Rash—Methotrexate—multiple sclerosis	0.00013	0.000877	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—multiple sclerosis	0.00013	0.000876	CcSEcCtD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000129	0.00231	CbGpPWpGaD
Rilpivirine—Headache—Methotrexate—multiple sclerosis	0.000129	0.000871	CcSEcCtD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000127	0.00227	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SRM—multiple sclerosis	0.000126	0.00226	CbGpPWpGaD
Rilpivirine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000124	0.00221	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000122	0.00219	CbGpPWpGaD
Rilpivirine—Nausea—Methotrexate—multiple sclerosis	0.000122	0.000826	CcSEcCtD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000122	0.00218	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—RPL5—multiple sclerosis	0.000122	0.00218	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000117	0.0021	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000115	0.00205	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.00011	0.00196	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000108	0.00193	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000108	0.00193	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000108	0.00193	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000106	0.0019	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000106	0.0019	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000106	0.00189	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000104	0.00186	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000104	0.00185	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000104	0.00185	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000101	0.0018	CbGpPWpGaD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0001	0.0018	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	9.87e-05	0.00176	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.63e-05	0.00172	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PGR—multiple sclerosis	9.6e-05	0.00172	CbGpPWpGaD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.36e-05	0.00167	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9.3e-05	0.00166	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.25e-05	0.00165	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.15e-05	0.00163	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	8.9e-05	0.00159	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	8.9e-05	0.00159	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.7e-05	0.00155	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SRM—multiple sclerosis	8.48e-05	0.00152	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.36e-05	0.00149	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.22e-05	0.00147	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GPC5—multiple sclerosis	8.14e-05	0.00145	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SRM—multiple sclerosis	7.86e-05	0.0014	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.72e-05	0.00138	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.67e-05	0.00137	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.61e-05	0.00136	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.59e-05	0.00136	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.51e-05	0.00134	CbGpPWpGaD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.3e-05	0.0013	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.27e-05	0.0013	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.88e-05	0.00123	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.88e-05	0.00123	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.87e-05	0.00123	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—RRM1—multiple sclerosis	6.74e-05	0.00121	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.73e-05	0.0012	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—VDR—multiple sclerosis	6.71e-05	0.0012	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.7e-05	0.0012	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.68e-05	0.00119	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.67e-05	0.00119	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.21e-05	0.00111	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.1e-05	0.00109	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	5.98e-05	0.00107	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	5.98e-05	0.00107	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.92e-05	0.00106	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.84e-05	0.00104	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SRM—multiple sclerosis	5.76e-05	0.00103	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.63e-05	0.00101	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—MYC—multiple sclerosis	5.54e-05	0.000989	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP27B1—multiple sclerosis	5.53e-05	0.000989	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP24A1—multiple sclerosis	5.53e-05	0.000989	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GPC5—multiple sclerosis	5.47e-05	0.000977	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.44e-05	0.000973	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.42e-05	0.000969	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.36e-05	0.000959	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.36e-05	0.000959	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.36e-05	0.000959	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	5.34e-05	0.000954	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.23e-05	0.000935	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.22e-05	0.000932	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.21e-05	0.000931	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.2e-05	0.00093	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.15e-05	0.000921	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.1e-05	0.000912	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GPC5—multiple sclerosis	5.06e-05	0.000905	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.86e-05	0.000869	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.86e-05	0.000869	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.59e-05	0.00082	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.57e-05	0.000816	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—RRM1—multiple sclerosis	4.53e-05	0.00081	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.49e-05	0.000803	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SRM—multiple sclerosis	4.35e-05	0.000778	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SRM—multiple sclerosis	4.25e-05	0.000759	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.23e-05	0.000756	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—RRM1—multiple sclerosis	4.19e-05	0.00075	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.12e-05	0.000736	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.1e-05	0.000732	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.06e-05	0.000725	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.06e-05	0.000725	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.03e-05	0.000721	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.95e-05	0.000706	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.9e-05	0.000696	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—BCHE—multiple sclerosis	3.87e-05	0.000692	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.71e-05	0.000663	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.64e-05	0.00065	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.51e-05	0.000628	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SRM—multiple sclerosis	3.39e-05	0.000606	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.14e-05	0.000562	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.00055	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000548	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000548	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.02e-05	0.00054	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3e-05	0.000536	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.99e-05	0.000535	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.99e-05	0.000535	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.8e-05	0.000501	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.75e-05	0.000492	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GPC5—multiple sclerosis	2.74e-05	0.000489	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—multiple sclerosis	2.67e-05	0.000476	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.62e-05	0.000468	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.62e-05	0.000468	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—BCHE—multiple sclerosis	2.6e-05	0.000465	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.42e-05	0.000433	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.42e-05	0.000433	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—BCHE—multiple sclerosis	2.41e-05	0.000431	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.39e-05	0.000427	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.39e-05	0.000427	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.33e-05	0.000417	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—APOE—multiple sclerosis	2.33e-05	0.000416	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.000415	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—RRM1—multiple sclerosis	2.27e-05	0.000405	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.18e-05	0.00039	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.09e-05	0.000374	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.09e-05	0.000373	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.05e-05	0.000366	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—POMC—multiple sclerosis	2e-05	0.000358	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.95e-05	0.000348	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.84e-05	0.000329	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.84e-05	0.000329	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALB—multiple sclerosis	1.82e-05	0.000326	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.81e-05	0.000324	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.8e-05	0.000322	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.77e-05	0.000316	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.69e-05	0.000301	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.57e-05	0.00028	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000277	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOE—multiple sclerosis	1.45e-05	0.000259	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.41e-05	0.000252	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.4e-05	0.000251	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.4e-05	0.00025	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.34e-05	0.00024	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000238	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.31e-05	0.000234	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.3e-05	0.000233	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—POMC—multiple sclerosis	1.24e-05	0.000223	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.23e-05	0.000219	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.21e-05	0.000216	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—multiple sclerosis	1.14e-05	0.000203	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.1e-05	0.000197	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.06e-05	0.00019	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.04e-05	0.000186	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—POMC—multiple sclerosis	9.13e-06	0.000163	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—multiple sclerosis	8.32e-06	0.000149	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOE—multiple sclerosis	8.03e-06	0.000143	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.02e-06	0.000143	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOE—multiple sclerosis	7.84e-06	0.00014	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—POMC—multiple sclerosis	6.9e-06	0.000123	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—POMC—multiple sclerosis	6.73e-06	0.00012	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—multiple sclerosis	6.29e-06	0.000112	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOE—multiple sclerosis	6.26e-06	0.000112	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—multiple sclerosis	6.14e-06	0.00011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—POMC—multiple sclerosis	5.37e-06	9.6e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—multiple sclerosis	4.9e-06	8.76e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.83e-06	8.63e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.15e-06	7.41e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.78e-06	6.76e-05	CbGpPWpGaD
